2 completed. 2 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 2 |
Follow Risk Stratification: new trials by email Literature Review of Risk Stratification trials Research Report on Risk Stratification
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Individual Early Warning Score (I-EWS) I-EWS with incorporated clinical assessment (Trigger Tool), Standard EWS - Control (Trigger Tool) - Early Warning Score, Risk Stratification | Not applicable | Completed | Herlev Hospital | 150000 | 2018-10-01 | 2019-11-04 |
| Risk Stratification-directed Therapy for AML With t(8;21) /AML1-ETO+ Consolidation with chemotherapy (CT) or autologous hematopoietic stem cell transplantation (auto-HSCT), Consolidation with auto-HSCT or HLA-matched HSCT, allogeneic HSCT - Acute Myeloid Leukemia, Risk Stratification | Not applicable | Completed | Nanfang Hospital, Southern Medical University | 207 | 2016-10-01 | 2023-08-08 |
Clinical Deterioration (1) · Leukemia, Myeloid, Acute (1)
Disease Attributes (1) · Disease Progression (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Leukemia (1) · Leukemia, Myeloid (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Drug Therapy (1)
Herlev Hospital (1) · Nanfang Hospital, Southern Medical University (1)
Denmark (1)
Dan Xu (1) · Kasper Iversen, MD, DMSci (1)